Psoriasis

Quintard B, Constant A, Bouyssou-Gauthier ML, Paul C, Truchetet F, Thomas P, Guiguen Y, Taieb A. Validation of a specific health-related quality of life instrument in a large cohort of patients with psoriasis: the QualiPso Questionnaire. Acta Derm Venereol. 2011 Oct;91(6):660-5. PubMed PMID: 21611686.

Vitiligo

Ezzedine K, Gauthier Y, Léauté-Labrèze C, Marquez S, Bouchtnei S, Jouary T, Taieb A. Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients. J Am Acad Dermatol. 2011 Nov;65(5):965-71. Epub 2011 May 25. PubMed PMID: 21616559.

Ezzedine K, Diallo A, Léauté-Labrèze C, Mossalayi D, Gauthier Y, Bouchtnei S, Cario-André M, Seneschal J, Boralevi F, Jouary T, Taieb A. Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients. Br J Dermatol. 2011 Jul;165(1):44-9. doi: 10.1111/j.1365-2133.2011.10311.x. Epub 2011 Jun 2. PubMed PMID: 21410675.

van Geel N, Speeckaert R, Taieb A, Picardo M, Böhm M, Gawkrodger DJ, Schallreuter K, Bennett DC, van der Veen W, Whitton M, Moretti S, Westerhof W, Ezzedine K, Gauthier Y; VETF members. Koebner's phenomenon in vitiligo: European position paper. Pigment Cell Melanoma Res. 2011 Jun;24(3):564-73. doi:10.1111/j.1755-148X.2011.00838.x. Epub 2011 Mar 7. Review. PubMed PMID: 21324101.

Dermatite atopique

Stalder JF, Barbarot S, Wollenberg A, Holm EA, De Raeve L, Seidenari S, Oranje A, Deleuran M, Cambazard F, Svensson A, Simon D, Benfeldt E, Reunala T, Mazereeuw J, Boralevi F, Kunz B, Misery L, Mortz CG, Darsow U, Gelmetti C, Diepgen T, Ring J, Moehrenschlager M, Gieler U, Taïeb A; PO-SCORAD Investigators Group. Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe. Allergy. 2011 Aug;66(8):1114-21. doi: 10.1111/j.1398-9995.2011.02577.x. Epub 2011 Mar 18. PubMed PMID: 21414011.

Dermatologie pédiatrique

Thoumazet F, Léauté-Labrèze C, Colin J, Mortemousque B. Efficacy of systemic propanolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients. Br J Ophthalmol. 2011 Jun 14. [Epub ahead of print] PubMed PMID: 21673014.

Léauté-Labrèze C, Prey S, Ezzedine K. Infantile haemangioma: part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. J Eur Acad Dermatol Venereol. 2011 Nov;25(11):1245-53. doi: 10.1111/j.1468-3083.2011.04102.x. Epub 2011 May 14. PubMed PMID: 21569112.

Léauté-Labrèze C, Prey S, Ezzedine K. Infantile haemangioma: part II. Risks, complications and treatment. J Eur Acad Dermatol Venereol. 2011 Nov;25(11):1254-60. doi: 10.1111/j.1468-3083.2011.04105.x. Epub 2011 May 14. PubMed PMID: 21569113.

Saint-Jean M, Léauté-Labrèze C, Mazereeuw-Hautier J, Bodak N, Hamel-Teillac D, Kupfer-Bessaguet I, Lacour JP, Naouri M, Vabres P, Hadj-Rabia S, Nguyen JM, Stalder JF, Barbarot S; Groupe de Recherche Clinique en Dermatologie Pédiatrique. Propranolol for treatment of ulcerated infantile hemangiomas. J Am Acad Dermatol. 2011 May;64(5):827-32. Epub 2011 Feb 25. PubMed PMID: 21353332.

Choi JS, Boralevi F, Brissaud O, Sánchez-Martín J, Te Morsche RH, Dib-Hajj SD, Drenth JP, Waxman SG. Paroxysmal extreme pain disorder: a molecular lesion of peripheral neurons. Nat Rev Neurol. 2011 Jan;7(1):51-5. Epub 2010 Nov 16. PubMed PMID: 21079636.

Cancérologie cutanée

Eisen T, Marais R, Affolter A, Lorigan P, Robert C, Corrie P, Ottensmeier C, Chevreau C, Chao D, Nathan PD, Jouary T, Harries M, Negrier S, Montegriffo E, Ahmad T, Gibbens I, James MG, Strauss UP, Prendergast S, Gore ME. Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies. Br J Cancer. 2011 Jul 26;105(3):353-9. doi:10.1038/bjc.2011.257. Epub 2011 Jul 12. PubMed PMID: 21750549; PubMed Central PMCID: PMC3172912.

Hu HH, Guedj M, Descamps V, Jouary T, Bourillon A, Ezzedine K, Taieb A, Bagot M, Bensussan A, Saiag P, Grandchamp B, Basset-Seguin N, Soufir N. Assessment of tyrosinase variants and skin cancer risk in a large cohort of French subjects. J Dermatol Sci. 2011 Nov;64(2):127-33. Epub 2011 Aug 22. PubMed PMID: 21906913.

Jouary T, Leyral C, Dreno B, Doussau A, Sassolas B, Beylot-Barry M, Renaud-Vilmer C, Guillot B, Bernard P, Lok C, Bedane C, Cambazard F, Misery L, Estève E, Dalac S, Machet L, Grange F, Young P, Granel-Brocard F, Truchetet F, Vergier B, Delaunay MM, Grob JJ; for the Groupe de Cancérologie Cutanée of the Société Française de Dermatologie. Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol. 2011 Jul 12. [Epub ahead of print] PubMed PMID:21750118.

Belin E, Ezzedine K, Stanislas S, Lalanne N, Beylot-Barry M, Taieb A, Vergier B, Jouary T. Factors in the surgical management of primary eccrine porocarcinoma: prognostic histological factors can guide the surgical procedure. Br J Dermatol. 2011 Nov;165(5):985-9. doi: 10.1111/j.1365-2133.2011.10486.x. Epub 2011 Sep 20. PubMed PMID: 21711331.

Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O'Day SJ, Sosman JA, Kirkwood JM, Eggermont AM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA; BRIM-3 Study Group. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011 Jun 30;364(26):2507-16. Epub 2011 Jun 5. PubMed PMID: 21639808.

Vergier B, Prochazkova-Carlotti M, de la Fouchardière A, Cerroni L, Massi D, De Giorgi V, Bailly C, Wesselmann U, Karlseladze A, Avril MF, Jouary T, Merlio JP. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases. Mod Pathol. 2011 May;24(5):613-23. Epub 2010 Dec 10. PubMed PMID: 21151100.

Inserm U1035

Rezvani HR, Ali N, Nissen LJ, Harfouche G, de Verneuil H, Taïeb A, Mazurier F. HIF-1α in epidermis: oxygen sensing, cutaneous angiogenesis, cancer, and non-cancer disorders. J Invest Dermatol. 2011 Sep;131(9):1793-805. doi:10.1038/jid.2011.141. Epub 2011 Jun 2. Review. PubMed PMID: 21633368.

Rezvani HR, Kim AL, Rossignol R, Ali N, Daly M, Mahfouf W, Bellance N, Taïeb A, de Verneuil H, Mazurier F, Bickers DR. XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas. J Clin Invest. 2011 Jan 4;121(1):195-211. doi: 10.1172/JCI40087. Epub 2010 Dec 1. PubMed PMID: 21123941; PubMed Central PMCID: PMC3007130.

Rezvani HR, Rossignol R, Ali N, Benard G, Tang X, Yang HS, Jouary T, de Verneuil H, Taïeb A, Kim AL, Mazurier F. XPC silencing in normal human keratinocytes triggers metabolic alterations through NOX-1 activation-mediated reactive oxygen species. Biochim Biophys Acta. 2011 Jun;1807(6):609-19. Epub 2010 Dec 15. PubMed PMID: 21167810; PubMed Central PMCID: PMC3086958.

Rezvani HR, Taïeb A. [Xeroderma pigmentosum: a useful model to study the relation between genomic mutations and cell transformation]. Med Sci (Paris). 2011 May;27(5):467-70. Epub 2011 May 25. French. PubMed PMID: 21609663.